glycyrrhizic acid has been researched along with 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, TQ; Liu, DP; Liu, Y; Lu, JH; Meng, QF; Teng, LS; Wang, D; Wang, ZY; Xie, J; Zhang, XL | 1 |
1 other study(ies) available for glycyrrhizic acid and 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one
| Article | Year |
|---|---|
ERKs and mitochondria-related pathways are essential for glycyrrhizic acid-mediated neuroprotection against glutamate-induced toxicity in differentiated PC12 cells.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cell Differentiation; Cell Survival; Chromones; Cytochromes c; Enzyme Inhibitors; Flavonoids; Glutamic Acid; Glycyrrhizic Acid; MAP Kinase Signaling System; Mitochondria; Morpholines; Neuroprotective Agents; PC12 Cells; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Rats; Signal Transduction | 2014 |